156 related articles for article (PubMed ID: 2293860)
1. The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.
Brescia RJ; Barakat RA; Beller U; Frederickson G; Suhrland MJ; Dubin N; Demopoulos RI
Cancer; 1990 Jan; 65(1):141-7. PubMed ID: 2293860
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
3. Influence of cellular DNA content on survival in ovarian carcinoma.
Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of abnormal nuclear DNA content in serous ovarian tumors.
Klemi PJ; Joensuu H; Kiilholma P; Mäenpää J
Cancer; 1988 Nov; 62(9):2005-10. PubMed ID: 3167812
[TBL] [Abstract][Full Text] [Related]
5. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
Friedlander ML; Hedley DW; Swanson C; Russell P
J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
[TBL] [Abstract][Full Text] [Related]
6. Effect of cellular DNA content on the prognosis of epithelial ovarian cancers.
Ozalp S; Yalcin OT; Gulbas Z; Tanir HM; Minsin T
Gynecol Obstet Invest; 2001; 52(2):93-7. PubMed ID: 11586035
[TBL] [Abstract][Full Text] [Related]
7. Tumor DNA content as a prognostic feature in advanced epithelial ovarian carcinoma.
Blumenfeld D; Braly PS; Ben-Ezra J; Klevecz RR
Gynecol Oncol; 1987 Jul; 27(3):389-402. PubMed ID: 3623235
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
[TBL] [Abstract][Full Text] [Related]
9. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
[TBL] [Abstract][Full Text] [Related]
10. The relationship of steroid receptor expression to nuclear DNA distribution and clinicopathological characteristics in epithelial ovarian tumors.
Friedlander ML; Quinn MA; Fortune D; Foo MS; Toppila M; Hudson CN; Russell P
Gynecol Oncol; 1989 Feb; 32(2):184-90. PubMed ID: 2910780
[TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
12. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.
Christov K; Vassilev N
Cancer; 1988 Jan; 61(1):121-5. PubMed ID: 3334938
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma.
Ishizu H
Jpn J Surg; 1989 Nov; 19(6):662-73. PubMed ID: 2558244
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
Volm M; Drings P; Kleine W; Mattern J
Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
[TBL] [Abstract][Full Text] [Related]
16. [Flow cytometric DNA analysis in colorectal cancer].
Ando Y; Tsuchiya A; Sekikawa K; Ishii Y; Yoshida T; Kimijima I; Abe R
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1571-5. PubMed ID: 2586468
[TBL] [Abstract][Full Text] [Related]
17. Cellular DNA content and survival in advanced ovarian carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Renz H; du Bois A; Kiechle-Schwarz M; Pfleiderer A
Cancer; 1994 Nov; 74(9):2509-15. PubMed ID: 7923008
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
19. Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary.
Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Terakawa N
Cancer; 1993 Aug; 72(3):804-8. PubMed ID: 8334634
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary.
Klemi PJ; Joensuu H; Salmi T
Cancer; 1990 Mar; 65(5):1189-93. PubMed ID: 2302667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
